My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Dynavax Technologies Corporation - Common Stock (NQ:DVAX)

15.38 UNCHANGED

Streaming Delayed Price Updated: 2:47 PM EST, Jan 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Dynavax Technologies Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

Why Are Dynavax Technologies Shares Skyrocketing Today? ↗

September 22, 2021

Clover Biopharmaceuticals has reported positive data for their COVID-19 vaccine candidate, SCB-2019, which achieved the primary and secondary efficacy endpoints in...

Via Benzinga

32 Stocks Moving In Wednesday's Mid-Day Session ↗

September 22, 2021

Gainers Marin Software Incorporated (NASDAQ: MRIN) shares climbed 53.1% to $8.71 following an announcement from management that the company entered into a revenue share...

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

September 13, 2021

Gainers Itamar Medical (NASDAQ:ITMR) shares increased by 46.58% to $30.25 during Monday's regular session. Trading volume for Itamar Medical's stock is 2.6 million...

Via Benzinga

72 Biggest Movers From Yesterday ↗

September 14, 2021

Gainers aTyr Pharma, Inc. (NASDAQ: LIFE) jumped 67% to settle at $9.15 on Monday as the company announced positive results from its Phase 1b/2a trial evaluating its lead...

Via Benzinga

45 Stocks Moving In Monday's Mid-Day Session ↗

September 13, 2021

Gainers Aterian, Inc. (NASDAQ: ATER) jumped 54.1% to $18.18. Investor presentation released on Friday is now circulating on news outlets. Itamar Medical Ltd. (NASDAQ: ITMR)...

Via Benzinga

Why Dynavax Technologies Stock Is Sinking Today ↗

September 13, 2021

A lost supply agreement for a partner's COVID-19 vaccine is hurting the biotech's shares today.

Via The Motley Fool

Why Dynavax Shares Are Trading Lower Today ↗

September 13, 2021

Dynavax Technologies Corp (NASDAQ: DVAX) is trading lower after the company announced Valneva SE (NASDAQ: VALN) received a termination notice from the United Kingdom...

Via Benzinga

Cramer Weighs In On Hut 8 Mining Corp, Ping Identity Holding And More ↗

September 13, 2021

On CNBC's "Mad Money Lightning Round," Jim Cramer advised a viewer to buy some Ethereum instead of Hut 8 Mining Corp (NASDAQ: HUT). Cramer likes Dynavax Technologies...

Via Benzinga

Valneva Shares Plunge As UK Terminates COVID-19 Vaccine Contract: What You Need Know ↗

September 13, 2021

The U.K. government has terminated its COVID-19 vaccine contract with Valneva SE (NASDAQ: VALN) over alleged breach of obligations. Related Content: ...

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

September 13, 2021

Gainers Itamar Medical (NASDAQ:ITMR) shares moved upwards by 44.37% to $29.8 during Monday's pre-market session. The market value of their outstanding shares is at $...

Via Benzinga

21 Stocks Moving in Monday's Pre-Market Session ↗

September 13, 2021

Gainers Itamar Medical Ltd. (NASDAQ: ITMR) rose 43% to $29.52 in pre-market trading. Zoll Medical said it has signed an agreement to acquire Itamar Medical for $31 per ADS in...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

September 07, 2021

Gainers Cellectar Biosciences (NASDAQ:CLRB

Via Benzinga

The Week Ahead In Biotech (Sept. 5-11): Focus On Conferences and Clinical Readouts In Another Quiet Week ↗

September 05, 2021

Biotech stocks extended their gains in the week ending Sept. 3, partly aided by the broader market strength. The news flow was fairly light ahead of the Labor Day holiday...

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

September 03, 2021

Gainers Cellect Biotechnology (NASDAQ:APOP) shares rose 68.9% to $9.29 during Friday's pre-market session. The company's market cap stands at $36.4 million....

Via Benzinga

10 Health Care Stocks Showing Unusual Options Activity In Today's Session ↗

September 02, 2021

This unusual options alert can help traders discover the next big trading opportunities. Traders will search for circumstances when the market estimation of an option diverges...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

September 02, 2021

Gainers Innate Pharma (NASDAQ:IPHA) shares rose 18.22% to $4.28 during Thursday's regular session. As of 12:30 EST, this security is trading at a volume of 20.8...

Via Benzinga

21 Stocks Moving in Wednesday's Pre-Market Session ↗

September 01, 2021

Gainers GBS Inc. (NASDAQ: GBS) rose 72.3% to $5.58 in pre-market trading. The company markets saliva test for diabetes management and previously announced collaboration on covid-...

Via Benzinga

The Daily Biotech Pulse: Assembly Bio Halts HBV Study, Moderna Initiates Submission For COVID-19 Booster Dose, FDA Nod For BeiGene, Tiziana Out-Licenses Foralumab ↗

September 02, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 1) AbbVie Inc. (NASDAQ: ABBV...

Via Benzinga

Why Dynavax Stock Is Skyrocketing 45.8% This Week ↗

August 27, 2021

One of the company's partners launched its COVID-19 vaccine in Taiwan.

Via The Motley Fool

The Daily Biotech Pulse: Merck Releases Twin Dose Of Positive Tidings, Astellas Voluntarily Pauses Gene Therapy Study, Ascendis Offering ↗

September 01, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 31) AC Immune SA (NASDAQ: ACIU...

Via Benzinga

The Daily Biotech Pulse: Early Approval For Ascendis' Pediatric Growth Hormone Deficiency Treatment, Redhill Biopharma Spikes On Positive COVID-19 Drug Data, RenovoRx IPO ↗

August 26, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 25) Abbvie Inc. (NYSE: ABBV)...

Via Benzinga

The Daily Biotech Pulse: VectivBio In M&A Mix, Sonnet Biotherapeutics Advances Candidate To Clinics, CEO Transitions At Galapagos, Talis Biomedical ↗

August 31, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 26) Agenus Inc. (NASDAQ: AGEN)...

Via Benzinga

The Daily Biotech Pulse: Lilly Strikes $1.6B R&D Collaboration, FSD Pulls Plug On COVID-19 Program, Cassava Sinks On Questions About Alzheimer's Drug ↗

August 25, 2021

ere's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 24) Agenus Inc. (NASDAQ: AGEN)...

Via Benzinga

The Daily Biotech Pulse: MorphoSys-Incyte Snag European Nod, Immutep Granted Chinese Patent, Bolt Biotherapeutics Strike Oncology Collaboration ↗

August 27, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 26) Agenus Inc. (NASDAQ: AGEN)...

Via Benzinga

Topics Intellectual Property

Why Coronavirus Stock Dynavax Crushed It Today ↗

August 23, 2021

There was some very good news on the authorization front for the company.

Via The Motley Fool

August 23, 2021

Medigen Vaccine Biologics Corporation and Dynavax Technologies Corporation (NASDAQ: DVAX) announced the rollout of their COVID-19 vaccine, MVC-COV1901, in...

Via Benzinga

60 Biggest Movers From Yesterday ↗

August 24, 2021

Gainers Trillium Therapeutics Inc. (NASDAQ: TRIL) shares jumped 188.8% to close at $17.59 on Monday after the company agreed to be acquired by Pfizer for $18.50 per share,...

Via Benzinga

Valneva Initiates Rolling Submission For COVID19 Vaccine Candidate In UK ↗

August 23, 2021

Valneva SE (NASDAQ: VALN) has commenced rolling submission for its COVID-19 vaccine candidate with the Medicines and Healthcare products Regulatory Agency (MHRA)...

Via Benzinga

Return on Capital Employed Overview: Dynavax Technologies ↗

August 20, 2021

Pulled from Benzinga Pro data Dynavax Technologies (NASDAQ:DVAX) posted Q2 earnings of $9.17 million, an increase from Q1 of 67.85%. Sales dropped to $52.77 million, a 36.68%...

Via Benzinga

Why Dynavax, Novavax, and Inovio Stocks Sank This Week ↗

August 20, 2021

Investors appeared to be rattled by the U.S. government's decision to move forward with booster doses of mRNA vaccines.

Via The Motley Fool

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.